Boston, Mass. (December 21, 2022) — Overjet, the industry leader in dental artificial intelligence, expands its detection capabilities with its third clearance from the U.S. Food and Drug Administration.
Overjet is the only dental AI technology that is FDA-cleared to quantify bone level measurements, detect and outline decay (cavities), and detect calculus on radiographs. The real-time analysis and annotations help dentists diagnose accurately, consistently, and confidently.
“AI-assisted dentistry adds a layer of data to assist doctors with their clinical decision-making,” said Teresa Dolan, DDS, Overjet’s Chief Dental Officer. “The recent FDA clearance for calculus detection helps clinicians be proactive in preventative care. Our mission is to improve oral health for all.”
Overjet continues to raise the bar for optimal patient health. One of the benefits of artificial intelligence is that it can process large amounts of data quickly. Overjet’s AI integrates with the digital imaging and practice management systems to analyze patient records from previous appointments and provide additional insights to assist in patient care.
To learn more about how Overjet is elevating dental care, visit overjet.com.
About Overjet
Founded by experts from MIT and Harvard School of Dentistry, Overjet is the industry leader in dental artificial intelligence, helping both providers and payers improve patient care. By combining deep expertise in dentistry and advanced engineering, Overjet develops accurate and quantified ways to detect pathologies and integrates actionable insights into clinical and operational workflows. Every day, dental groups (DSOs), private dental practices, and dental payers rely on the information provided by Overjet to enhance patient care. To learn more, visit overjet.com.
*Some features are not available in all areas.
